VAERS reports by lot

Moderna COVID-19 lot 027D21A: VAERS reports

36 VAERS reports list lot 027D21A as a Moderna COVID-19 vaccine, received between 2021-04-10 and 2022-09-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
17%
Marked serious
1
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular2818%
General / Systemic (non-local)2717%
Neurological2214%
Injection-site / Local reaction2214%
Gastrointestinal1711%
Allergic / Anaphylactic106%
Musculoskeletal106%
Respiratory96%
Dermatological (non-injection-site)53%
Thrombotic / Hematological43%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Texas5
North Carolina3
Oklahoma3
New Jersey3
Connecticut3
Maine2
New York2
Florida2
Minnesota1
Washington1
Pennsylvania1

Reports by month received

2021-041
2021-061
2021-073
2021-0812
2021-096
2021-103
2021-111
2021-121
2022-033
2022-051
2022-082
2022-092

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.